AndrewQuonMD
Nuclear Medicine • Stanford, CAAssistant Professor, Radiology, Stanford University Medical Center
Are you Dr. Quon?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 44 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Andrew Quon, MD is a board certified nuclear medicine physician in Stanford, California. He is currently licensed to practice medicine in California. He is affiliated with Stanford Health Care, Lucile Packard Children's Hospital Stanford, and VA Palo Alto Heath Care.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Nuclear Medicine, 2000 - 2002
Kaiser Permanente Northern California (Oakland)Internship, Internal Medicine, 1998 - 1999
University of Texas Southwestern Medical SchoolClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2025- American Board of Nuclear Medicine Nuclear Medicine
Clinical Trials
- Evaluating Sunitinib Therapy in Renal Cell Carcinoma Using F-18 FDG PET/CT and DCE MRI Start of enrollment: 2007 Oct 01
- FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma Start of enrollment: 2017 Sep 07
- Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 1 citationsIn search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradi...Michelle Jun, Harlan Pinto, Quynh-Thu Le, Andrew Quon, Wendy Hara
Plos One. 2023-01-01 - 1 citationsDetection of Recurrence After Thoracic Stereotactic Ablative Radiotherapy Using FDG-PET-CT.Quaovi H Sodji, Jeremy P Harris, Andrew Quon, Leslie A Modlin, Brianna Lau
Clinical Lung Cancer. 2022-05-01 - 3 citations18F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.Matthias R. Benz, Wesley R Armstrong, Francesco Ceci, Giulia Polverari, Timothy R. Donahue
Journal of Nuclear Medicine. 2021-07-16
Press Mentions
Molecular Imaging Pinpoints Source of Chronic Back PainJune 16th, 2011
